Ziege anti-Kaninchen IgG (Heavy & Light Chain) Antikörper (DyLight 488)

Produktnummer ABIN400260

Produktdetails

Target: IgG

Bindungsspezifität: Heavy & Light Chain

Reaktivität: Kaninchen

Wirt: Ziege

Konjugat: DyLight 488

Applikation: Flow Cytometry (FACS), Immunofluorescence (IF)

Produktmerkmale: Goat anti-rabbit IgG (H&L) - Affinity Pure, DyLight 488 Conjugate.
Fluorphore: DyLight 488 (Ex = 493 nm, Em = 518 nm).
Fluor Protein Ratio: Moles DyLight 488 per Mole Antibody.

Aufreinigung: Affinity purified using solid phase mouse IgM (H&L)

Reinheit: > 95 % based on SDS-PAGE

Immunogen: Purified rabbit IgG, whole molecule

Anwendungsinformationen

Applikationshinweise: This conjugate is suitable for immunomicroscopy, flow cytometry.
The optimal working dilution should be determined by the investigator. Suggested starting dilution: 1:20 - 1:2,000 for most applications

Kommentare:

Country of Origin: Goat serum was obtained from healthy animals of US origin, under the care of a registered veterinarian.

DyLight is a trademark of Thermo Fisher Scientific, Inc. and its subsidiaries.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: 1.0 mg/mL

Buffer: 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free. 0.05 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Handhabung: Product is photosensitive and should be protected from light.

Lagerung: 4 °C/-20 °C

Referenzen

Surowiec, Battle, Ward, Schlecht, Khoury, Robbins, Wojtys, Caird, Kozloff: "A xenograft model to evaluate the bone forming effects of sclerostin antibody in human bone derived from pediatric osteogenesis imperfecta patients." in: Bone, Vol. 130, pp. 115118, (2020) (PubMed).

Antigendetails

Target: IgG

Abstract: IgG Produkte

Substanzklasse: Antibody